6-K

CURRENT REPORT OF FOREIGN ISSUER

Company: XTL BIOPHARMACEUTICALS LTD
Filed: May 30, 2019
Period of Report: May 30, 2019
Accession Number: 0001213900-19-009781

View Document ↗ View on SEC.gov ↗